Clinical Trial Update: Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated continuous glucose monitoring in patients with type 2 diabetes inadequately controlled on metformin, assessing glycemic profi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Glucophage (metformin)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED